Literature DB >> 28275034

Critical Evaluation of the Quality and Recommendations of Clinical Practice Guidelines for Nasopharyngeal Carcinoma.

Yu-Pei Chen1, Ya-Qin Wang1, Wen-Fei Li1, Lei Chen1, Cheng Xu1, Tai-Xiang Lu1, Ai-Hua Lin2, Ji-Jin Yao1, Yang-Chan Li1, Ying Sun1, Yan-Ping Mao1, Jun Ma1.   

Abstract

Background: Given the distinct biological characteristics and regional distribution of nasopharyngeal carcinoma (NPC) compared with other head and neck cancers, and uncertainties regarding therapeutic strategies, physicians require high-quality clinical practice guidelines (CPGs) to provide transparent recommendations for NPC treatment. This study aimed to critically appraise the quality of NPC CPGs and assess the consistency of their recommendations.
Methods: We identified CPGs that provided recommendations on the diagnosis and management of NPC published up to December 2015. Four investigators independently appraised CPG quality using the Appraisal of Guidelines for Research & Evaluation (AGREE) II instrument. Key recommendations by CPGs were also evaluated.
Results: A total of 7 CPGs were eligible for this study: 5 produced by professional organizations or governmental agencies and 2 were developed based on expert consensus. Of the 6 AGREE II domains, the applicability domain scored consistently low across CPGs (range, 13.5%-30.2%); no CPG achieved a score of >50% in all 6 domains. The scope and purpose domain (≥73.6% for 4 CPGs) and editorial independence domain (≥75.0% for 6 CPGs) scored highest. Of the 23 AGREE II items, 9 scored less than half of the points available in all 7 CPGs. The recommendations by CPGs were consistent in general; heterogeneity mainly existed among recommended therapeutic strategies. Conclusions: Variation exists in NPC CPG development processes and recommendations. Increased efforts are required to make comprehensive resources available to guide healthcare providers and enhance delivery of high-quality, evidence-based care for NPC. International collaboration is necessary to enable the development of high-quality and regionally relevant CPGs for NPC.
Copyright © 2017 by the National Comprehensive Cancer Network.

Entities:  

Mesh:

Year:  2017        PMID: 28275034     DOI: 10.6004/jnccn.2017.0033

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  10 in total

Review 1.  Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma.

Authors:  Elaine Johanna Limkin; Pierre Blanchard
Journal:  Br J Radiol       Date:  2019-05-31       Impact factor: 3.039

2.  Comparison of different guidelines for oral cancer.

Authors:  Hugo Fontan Köhler; Hisham Mehanna; Jatin P Shah; Alvaro Sanabria; Johannes Fagan; Moni A Kuriakose; C Rene Leemans; Brian O'Sullivan; Suren Krishnan; Luiz P Kowalski
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-15       Impact factor: 2.503

3.  Dental caries prevention in children and adolescents: a systematic quality assessment of clinical practice guidelines.

Authors:  Andrea Seiffert; Carlos Zaror; Claudia Atala-Acevedo; Andrea Ormeño; María José Martínez-Zapata; Pablo Alonso-Coello
Journal:  Clin Oral Investig       Date:  2018-03-09       Impact factor: 3.573

Review 4.  Quality Assessment of Cancer Pain Clinical Practice Guidelines.

Authors:  Zhigang Zhang; Xiao Cao; Qi Wang; Qiuyu Yang; Mingyao Sun; Long Ge; Jinhui Tian
Journal:  Front Oncol       Date:  2022-05-27       Impact factor: 5.738

5.  Importance and Presence of High-Quality Evidence for Clinical Decisions in Neurosurgery: International Survey of Neurosurgeons.

Authors:  Jill Martens; Guido de Jong; Maroeska Rovers; Gert Westert; Ronald Bartels
Journal:  Interact J Med Res       Date:  2018-10-12

6.  A critical appraisal of the quality of head and neck cancer imaging guidelines using the AGREE II tool: A EuroAIM initiative.

Authors:  Valeria Romeo; Arnaldo Stanzione; Sirio Cocozza; Lorenzo Ugga; Renato Cuocolo; Arturo Brunetti; Sotirios Bisdas
Journal:  Cancer Med       Date:  2018-12-21       Impact factor: 4.452

7.  Survival impact of additional induction chemotherapy in nasopharyngeal carcinoma with chronic hepatitis B infection: a retrospective, bi-center study.

Authors:  Haojiang Li; Mingyang Chen; Shuqi Li; Chao Luo; Xuemin Qiu; Guangying Ruan; Yanping Mao; Guoyi Zhang; Lizhi Liu
Journal:  Ann Transl Med       Date:  2022-07

Review 8.  Surveillance tools for detection of recurrent nasopharyngeal carcinoma: An evidence-based review and recommendations.

Authors:  Andrew Thamboo; Kim H Tran; Annette X Ye; Issraa Shoucair; Basel Jabarin; Eitan Prisman; Cathie Garnis
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-04-21

9.  Outcomes of Adding Induction Chemotherapy to Concurrent Chemotherapy for Nasopharyngeal Carcinoma Patients with Moderate-Risk in the Intensity-Modulated Radiotherapy Era.

Authors:  Zhen Su; Guo-Rong Zou; Jie Tang; Xiu Yue Li; Fang-Yun Xie
Journal:  Ther Clin Risk Manag       Date:  2020-03-26       Impact factor: 2.423

10.  Chemoradiotherapy combined with NK cell transfer in a patient with recurrent and metastatic nasopharyngeal carcinoma inducing long-term tumor control: A case report.

Authors:  Yuan-Yuan Jin; Wen-Zhuo Yang; Sen Zou; Zheng-Yang Sun; Chun-Tao Wu; Zhao-Yong Yang
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.